Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Oncotarget|October 15, 2016
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approachMichelangelo Fiorentino, Elisa Gruppioni, Francesco Massari, et al.
American Journal of Epidemiology|April 13, 2019
Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort StudyRenata Zelic, Daniela Zugna, Matteo Bottai, et al.
International Journal of Molecular Sciences|May 27, 2023
Multi-Gene Next-Generation Sequencing Panel for Analysis of <i>BRCA1</i>/<i>BRCA2</i> and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate CancerThais Maloberti, Antonio De Leo, Sara Coluccelli, et al.
Translational Lung Cancer Research|December 15, 2022
ADK-VR2, a cell line derived from a treatment-naïve patient with <i>SDC4-ROS1</i> fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLCFrancesca Ruzzi, Stefania Angelicola, Lorena Landuzzi, et al.
American Journal of Clinical Pathology|September 19, 2025
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumorsSofia Melotti, Francesca Ambrosi, Tania Franceschini, et al.
Urologic Oncology|November 16, 2020
The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trialRiccardo Schiavina, Matteo Droghetti, Giacomo Novara, et al.
Frontiers in Oncology|May 29, 2026
Update of the MSKCC nomogram for metastatic progression and its role in active surveillance: the Italian TPCP cohortNicolas Destefanis, Daniela Zugna, Valentina Fiano, et al.
Pathology Oncology Research : POR|July 12, 2017
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign OutcomeFrancesco Massari, Chiara Ciccarese, Ondrej Hes, et al.
Molecular Cancer Research : MCR|November 10, 2020
Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and SerumKathryn L Penney, Svitlana Tyekucheva, Jacob Rosenthal, et al.
JCO Precision Oncology|December 5, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring <i>BRAF</i> Class 3 MutationsAlessandro Di Federico, Stefania Angelicola, Mariateresa Frascino, et al.
Pageof 12